Cardioversion with lidocaine of vagally associated atrial fibrillation in two dogs

Journal of Veterinary Cardiology

Volumn 7, Issue 2, 2005, Pages 143-148

  Moïse, N Sydney ^a   Pariaut, Romain ^a   Gelzer, Anna R M ^a   Kraus, Marc S ^a   Jung, Seung Woo ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Atrial fibrillation; Canine

Indexed keywords

ACEPROMAZINE; BUTORPHANOL; DEXAMETHASONE; EQUANOL; FUROSEMIDE; LIDOCAINE;

ANIMAL DISEASE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; DRUG EFFICACY; DRUG MECHANISM; ECG ABNORMALITY; HEART ATRIUM FIBRILLATION; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; SINUS ARRHYTHMIA; SINUS RHYTHM; SYNCOPE; VAGUS TONE;

CANIS FAMILIARIS;

EID: 33745483626     PISSN: 17602734     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvc.2005.09.004     Document Type: Article

References (24)

1. Menaut P., Bélanger M.C., Beauchamp C., et al. Atrial fibrillation in dogs with and without structural or functional cardiac disease: a retrospective study of 109 cases. J Vet Cardiol 2 (2005) 75-83
2. Bright J.M., Martin J.M., and Mama K. A retrospective evaluation of transthoracic biphasic electrical cardioversion for atrial fibrillation in dogs. J Vet Cardiol 2 (2005) 85-96
3. Brundel B.J.J.M., Melnyk P., Rivard L., et al. The pathology of atrial fibrillation in dogs. J Vet Cardiol 2 (2005) 121-129
4. Grogan M., Smith H.C., Gersh B.J., et al. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 69 (1992) 1570-1573
5. Waldo A.L. Mechanisms of atrial fibrillation. J Cardiovasc Electrophysiol 14 (2003) S267-S274
6. Pariaut R., Koetje B.D., Renaud-Farrell S., et al. Spatio-temporal organization of induced atrial fibrillation in German shepherd dogs with inherited ventricular arrhythmias. [Abstract]. J Vet Intern Med 19 (2005) 416
7. David D., Lang R.M., Neumann A., et al. Parasympathetically modulated antiarrhythmic action of lidocaine in atrial fibrillation. Am Heart J 119 (1990) 1061-1068
8. Tse H.F., and Lau C.P. Does sinus rhythm beget sinus rhythm? Effects of prompt cardioversion on the frequency and persistence of recurrent atrial fibrillation. Card Electrophysiol Rev 7 (2003) 359-365
9. Zickmann B., Hofmann H.C., Pottkamper C., et al. Changes in heart rate variability during induction of anesthesia with fentanyl and midazolam. J Cardiothorac Vasc Anesth 10 (1996) 609-613
10. Michaloudis D., Kochiadakis G., Georgopoulou G., et al. The influence of premedication on heart rate variability. Anaesthesia 53 (1998) 446-453
11. Liu L., and Nattel S. Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity. Am J Physiol 273 (1997) H805-H816
12. Skanes A.C., Manfapati R., Berenfeld O., et al. Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart. Circulation 98 (1998) 1236-1248
13. Wang Z., Feng J., and Nattel S. Idiopathic atrial fibrillation in dogs: electrophysiologic determinants and mechanisms of antiarrhythmic action of flecainide. J Am Coll Cardiol 26 (1995) 277-286
14. Griffioen K.J.S., Venkatesan P., Huang Z., et al. Fentanyl inhibits GABAergic neurotransmission to cardiac vagal neurons in the nucleus ambiguus. Brain Res 1007 (2004) 109-115
15. Yelich M.R., Euler D.E., Wehrmacher W.H., et al. Parasympathetic influence on atrial vulnerability in the puppy. Am J Physiol 235 (1978) H683-H689
16. Nattel S., Kneller J., Zou R., et al. Mechanisms of termination of atrial fibrillation by class I antiarrhythmic drugs. J Cardiovasc Electrophysiol 14 (2003) S133-S139
17. Jalife J. Experimental and clinical AF mechanisms: bridging the divide. J Interv Card Electrophysiol 9 (2003) 85-92
18. Shinagawa K., Mitamura H., Takeshita A., et al. Determination of refractory periods and conduction velocity during atrial fibrillation using atrial capture in dogs. J Am Coll Cardiol 35 (2000) 246-253
19. Wijffels M.C.E.F., Dorland R., Mast F., et al. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat. Circulation 102 (2000) 260-267
20. Kawase A., Ikeda T., Nakazawa K., et al. Widening of the excitable gap and enlargement of the core reentry during atrial fibrillation with a pure sodium channel blocker in canine atria. Circulation 107 (2003) 905-910
21. Kneller J., Kalifa J., Zou R., et al. Mechanisms of atrial fibrillation termination of pure sodium channel blockade in an ionically-realistic mathematical model. Circ Res 96 (2005) e35-e47
22. Hollman M.W., Fischer L.G., and Byford A.M. Local anesthetic inhibition of M1 muscarinic acetylcholine signaling. Anesthesiology 93 (2000) 497-509
23. Yunoki M., Nakahara T., Mitani A., et al. Role of the M2 muscarinic receptor pathway in lidocaine-induced potentiation of the relaxant response to atrial natriuretic peptide in bovine tracheal smooth muscle. Naunyn-Schmiedebergs Arch Pharmacol 367 (2003) 76-79
24. Elvan A., Wylie K., and Zipes D.P. Pacing-induced chronic atrial fibrillation impairs sinus node function in dog. Electrophysiological remodeling. Circulation 94 (1996) 2953-2960